The AI-Native PE Firm: A Setup Checklist for AI-Led Rollups

The arbitrage in low-margin buy-and-build is no longer mostly multiple expansion. It is coordination cost — and the firms that compound it will look different from day one. This is the checklist we would hand a founding partner standing up a new firm — or an existing firm spinning up a dedicated strategy — whose thesis is AI-led rollups: buy fragmented, operationally similar businesses and create value primarily by deploying agent-based automation across them.

An AI-native firm is not a firm that uses a chatbot to draft IC memos. It is a firm whose sourcing, diligence, value creation, and measurement are built around a repeatable, auditable AI operating model from day one — designed so that every deal makes the next deal cheaper to underwrite and faster to integrate, because evidence, integration patterns, and playbooks accumulate as firm assets rather than as memory in one operating partner's head.

Work the phases in order. Each one gates the next.

Phase 1 — Thesis and strategy

• Write the arbitrage down in one sentence. Name the replacement for compressed buy-and-build multiple arbitrage. For AI-led rollups it is usually coordination cost: scheduling, dispatching, exception handling, invoice matching, reconciliation. If your thesis is "AI will make things better," you do not have a thesis.
• Pick one or two verticals, not "fragmented industries." Compounding only happens when add-ons fail in the same ways — same bottlenecks, same systems of record, same playbooks. A distributor rollup and a med-spa rollup share almost nothing operationally.
• Screen the vertical against an explicit profile. Heuristics, not sourced stats: EBITDA margin under ~10%, labor above ~35% of revenue with visible supervisory/back-office load, commoditized service, repeatable ops, APIs on aging systems. State the downside symmetrically — same leverage that amplifies a one-point save also amplifies a one-point miss — and set a minimum absolute-EBITDA floor.
• Decide platform-first vs. cohort-first. Platform-first buys an anchor and bolts on; cohort-first underwrites similar targets as one thesis and sequences by integration readiness. Cohort-first is harder to finance, but natural when the value driver is a shared automation layer.
• Model the value bridge with AI as a line item, not a vibe. Separate classic levers (procurement, shared back office, cross-sell) from the automation lever, expressed as % of revenue in operating cost with an adoption ramp. If you cannot decompose it, an LP or IC eventually will.

Phase 2 — Fund and firm structure

• Size the fund to the integration math, not just the acquisition math. Reserve explicitly for add-on capital, year-one integration spend (discovery, engineering, change management), and working-capital needs of thin-margin targets — do not let integration appear as surprise portco opex.
• Line up credit that understands the thesis. Underwrite assuming lenders give no adjusted-EBITDA credit for projected automation savings. Confirm covenant headroom for front-loaded year-one spend and an acquisition / delayed-draw facility for add-ons. Thin-margin businesses get levered lightly.
• Write the AI thesis into the LP conversation honestly. Commit to projected-versus-actual on every automation intervention, and say the compounding moat takes portfolio-data cycles to materialize. Coordinate projection format with fund counsel — US Marketing Rule territory for registered advisers.
• Decide where the operating capability lives. In-house (highest fixed cost, fastest compounding), captive services entity (LP/regulatory scrutiny on affiliated fees), or external partners (fastest start, weakest moat). Most new firms start hybrid and in-source as the playbook library grows.
• Set the data-rights posture before the first LOI — in two documents. Cross-portfolio pattern IP allocation belongs in the LPA; per-deal data access belongs in the SPA. Retrofitting either after close is painful, and the allocation constrains what conveys at exit (Phase 6).
• Stand up AI governance at two levels. Portco: one-page policy — define which agent activity is recorded, which actions require human approval, which systems own transactions, and how scenarios may be used. Adviser-level compliance is a separate CCO document.

Phase 3 — The operating team

• Hire an operating partner who has shipped automation into low-margin operations, not a strategy consultant who has written about it. Quiet non-adoption is the failure mode; the countermove is putting agents behind existing workflows (ERP, email, PDFs) so work stops arriving rather than a tool appearing.
• Secure integration engineering capacity — in-house, partner, or managed runtime. Someone still has to generate, deploy, and govern agent-consumable interfaces into systems of record. First integration to a given system is a project; every redeployment after that should be configuration. That cost curve is the strategy.
• Make someone own the playbook library. Capture interventions — preconditions, gates, measured outcomes — in a documented, versioned, reusable format. Unowned knowledge assets decay into folklore.
• Train the deal team on the assessment methodology. Every partner should explain to IC how a readiness score and savings estimate were computed. Numbers the deal team cannot defend line-by-line should not be in the memo.

Phase 4 — Sourcing and diligence machinery

• Build a company universe for the vertical, enriched and scored. Firmographics + tech stack, screened against the Phase 1 profile, so sourcing starts from a ranked list rather than banker inbound.
• Add an AI-readiness workstream to standard diligence — with structure. Structured management interviews (self-serve or multi-department) with per-dimension confidence scores beat ad-hoc "tech diligence calls" that do not compare across targets.
• Insist on deterministic, auditable scoring. Same inputs, same score, every time — so an associate can reproduce the number. Treat any black-box score as a soft signal, not IC evidence.
• Underwrite three scenarios with visible assumptions. Conservative / base / aggressive on modeled cash flows, adoption as an S-curve not a step. If IC disagrees with the ramp, they must be able to change it and re-run. Know what the tooling leaves out: scenario engines (ours included) typically model acquisition price, ramped net savings, and exit value — year-one integration spend is not a modeled line item, so add it in your own fund model. Once you do, sanity-check IRR against MOIC: front-loaded spend can make the cash-flow series non-conventional, where IRR alone misleads.
• Split automation-specific deal conditions correctly. Diligence / LOI: API access, data-export feasibility, change-of-control clauses in key software contracts. SPA: assignability reps, data rights per Phase 2, retention for process owners who will own approval gates.

Phase 5 — The first 100 days per add-on

• Run consulting discovery before writing the value creation plan. Capture management evidence first; synthesis should hand assessment a pre-populated tech stack and workflow map. By the third add-on, discovery should compress toward validation — measure whether it does.
• Sequence interventions by evidence, not enthusiasm. Benchmark, diagnose, then plan with projected ROI per intervention. The money is usually in the boring coordination layer, not a flashy customer-facing agent.
• Gate consequential execution behind explicit approval. Define the owner, approval condition, and projected number before the applicable work runs, then retain the run record and approval decision.
• Align portco management incentives with the interventions. Retention keeps people in seats; tie a slice of equity rollover or bonus to measured outcomes so gate owners have upside in the result.
• Leave the systems of record in charge. Billing, ERP, CRM, and compliance keep owning transactions of record. Orchestrate into them; do not rip them out.

Phase 6 — Measurement and the compounding loop

• Track projected-versus-actual on every intervention, forever. Highest-leverage discipline on the list: keeps the deal team honest, gives LPs falsifiable reporting, and recalibrates underwriting as loops close.
• Feed outcomes back into the playbook library. Beats become patterns with evidence; misses become documented precondition failures. Skip this and the strategy collapses into one-off projects.
• Report the automation lever separately at exit — and decide what conveys. Measured per-intervention PvA across add-ons is a different claim than asserted synergies. If the automation layer is firm IP, license it, embed it, or offer transition services — decide before the sale process. Late-hold add-ons may exit before savings season.

What we can and cannot tell you

MigrateForce is live and free for teams evaluating the beta. The four-agent pipeline behind this checklist — Consult, Assess, Plan, Execute — supports structured discovery, readiness assessment with three financial scenarios, PE-native intervention planning, and approval-gated execution for supported migration paths. The Value Creation workflow and execution path are still being productionized. Active migration runs cannot currently be paused and resumed, and results still depend on company evidence, assumptions, systems, and change work. The checklist above is the operating model the product is built around; it must earn its proof deal by deal through the Phase 6 measurement loop.